Sharpless Wonders Why Cancer Success Doesn't Translate To Other Diseases

Acting US FDA commissioner also said he wants to be nominated to the permanent position.

FDA acting Commissioner Ned Sharpless at Reagan-Udall Foundation for FDA. (1)
Acting FDA Commissioner Norman Sharpless wants the success in cancer drug development disseminated to other disease areas. • Source: File photo

More from R&D

More from Pink Sheet